Biora Therapeutics, Inc. PROG
0.88 0.00 (+0.00%)
At closeMay 9, 2022, 12:00 AM EDT
0.84 Day range 0.92
52-week range unavailable
News
benzinga.com 81 Biggest Movers From Yesterday Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
benzinga.com Earnings Scheduled For November 10, 2021 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
benzinga.com The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Here's a roundup of top developments in the biotech space over the last 24 hours:
benzinga.com 30 Stocks Moving In Tuesday's Mid-Day Session Gainers- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 155 companies achieved new lows for the year.
benzinga.com Earnings Scheduled For August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows.
benzinga.com Earnings Scheduled For May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday Monday morning saw 78 companies set new 52-week lows.- benzinga.com Earnings Scheduled For August 13, 2020 Companies Reporting Before The Bell • Tapestry Inc. (NYSE:TPR) is estimated to report quarterly loss at $0.57 per share on revenue of $662.44 million.
- benzinga.com 75 Biggest Movers From Friday Gainers Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) shares rose 95% to close at $39.00 on Friday after the company priced its IPO at $20 per share.